SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 026

1. What are the main characteristics of bronchogenic carcinomas?

Bronchogenic carcinoma is the most common primary malignant tumor of the lung and a leading cause of cancer-related death worldwide. Most cases are strongly associated with cigarette smoking. The tumor usually arises from the bronchial epithelium after progressive dysplastic and malignant transformation.

Bronchogenic carcinomas are aggressive tumors with early local invasion and distant metastasis. Patients commonly present with cough, hemoptysis, chest pain, dyspnea, or recurrent pneumonia. Some tumors produce paraneoplastic syndromes due to ectopic hormone secretion. Histologically, they are classified into several major subtypes.

Early diagnosis is often difficult because symptoms appear late. Prognosis depends mainly on histological type and clinical stage.

2. Which etiologic agents have been known to promote lung cancers?

Cigarette smoking is the single most important etiological factor responsible for lung cancer. Passive smoking also increases the risk. Occupational exposure to asbestos, arsenic, chromium, nickel, beryllium, and uranium contributes significantly. Radon gas exposure is an important cause, especially in underground miners and poorly ventilated buildings.

Air pollution and diesel exhaust increase the incidence of lung cancer. Previous pulmonary fibrosis and chronic lung disease predispose to malignant transformation. Ionizing radiation is another recognized carcinogenic factor.

Genetic susceptibility influences individual risk. Smoking combined with asbestos exposure produces a synergistic increase in lung cancer risk.

Avoidance of tobacco remains the most effective preventive measure.

3. List the main histologic types of bronchogenic carcinomas.

Bronchogenic carcinomas are classified into four major histological types. Squamous cell carcinoma arises from bronchial epithelium and often shows keratinization. Adenocarcinoma originates from gland-forming epithelial cells and is the most common type overall.

Small cell carcinoma is a highly malignant neuroendocrine tumor with early metastasis. Large cell carcinoma is an undifferentiated malignant epithelial tumor lacking features of the other types.

Additional less common variants include adenosquamous carcinoma and sarcomatoid carcinoma. Histological classification guides treatment decisions.

Molecular testing is especially important in adenocarcinoma. Accurate pathological diagnosis is essential for prognosis and therapy.

 

4. What is the most common histologic type of lung cancer?

Adenocarcinoma is currently the most common histologic type of lung cancer worldwide. It occurs in both smokers and non-smokers but is particularly common among non-smokers and women. The tumor usually arises in the peripheral parts of the lung.

Histologically, it forms glands or produces mucin. Many tumors harbor mutations involving EGFR, ALK, KRAS, or other molecular pathways. Molecular testing is essential because targeted therapy improves survival in selected patients.

Adenocarcinoma may invade the pleura and metastasize early. Clinical presentation includes cough, dyspnea, chest pain, or incidental radiological detection.

Prognosis depends primarily on tumor stage at diagnosis.

5. How are lung cancers divided according to their response to chemotherapy?

Lung cancers are broadly divided into small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) according to their biological behavior and response to treatment. Small cell carcinoma responds well initially to chemotherapy and radiotherapy because of its high mitotic activity.

However, recurrence is common, and long-term survival remains poor. Non-small cell carcinomas include squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. These tumors respond less effectively to chemotherapy than small cell carcinoma.

Surgical resection is the preferred treatment for localized NSCLC. Targeted therapy and immunotherapy have significantly improved outcomes in selected patients.

Accurate classification is essential for choosing appropriate treatment.

6. Which types of carcinomas are most closely related to smoking?

Squamous cell carcinoma and small cell carcinoma show the strongest association with cigarette smoking. Nearly all patients with small cell carcinoma have a significant smoking history.

Squamous cell carcinoma develops through squamous metaplasia and dysplasia induced by tobacco smoke. Large cell carcinoma also has a strong association with smoking. Adenocarcinoma is associated with smoking but also commonly occurs in non-smokers.

Tobacco smoke contains numerous carcinogens that produce genetic mutations in bronchial epithelial cells. The risk increases with the duration and intensity of smoking.

Smoking cessation substantially reduces future cancer risk. Tobacco control remains the most effective preventive strategy.

7. In which parts of the lung do most bronchogenic carcinomas arise?

The site of origin varies according to the histological subtype of bronchogenic carcinoma. Squamous cell carcinoma usually arises centrally in the main, lobar, or segmental bronchi. Small cell carcinoma also commonly originates in the central bronchi.

Adenocarcinoma most frequently develops in the peripheral lung parenchyma, often near the pleura. Large cell carcinoma may arise either centrally or peripherally. Peripheral tumors may invade the pleura and chest wall.

Central tumors commonly produce bronchial obstruction, atelectasis, and recurrent pneumonia. Knowledge of tumor location assists radiological diagnosis and biopsy planning.

Tumor site also influences clinical presentation and surgical management.

8. Describe the most common pathways of lung cancer spread.

Lung carcinoma spreads by direct invasion, lymphatic dissemination, hematogenous metastasis, and transcoelomic extension. Direct invasion involves the pleura, chest wall, mediastinum, diaphragm, or pericardium. Lymphatic spread first involves hilar and mediastinal lymph nodes.

Hematogenous spread commonly affects the brain, liver, adrenal glands, bones, and opposite lung. Pleural involvement may produce malignant pleural effusion.

Tumor cells may invade major blood vessels and bronchi. Small cell carcinoma metastasizes particularly early and extensively. Distant metastases are often present at the time of diagnosis. The extent of metastatic spread is a major determinant of prognosis.

9. What are the main pathologic features of squamous cell carcinoma of the lung?

Squamous cell carcinoma usually arises centrally from the major bronchi and is strongly associated with cigarette smoking. It develops through a sequence of squamous metaplasia, dysplasia, carcinoma in situ, and invasive carcinoma.

Grossly, the tumor forms a firm gray-white mass that may obstruct the bronchial lumen. Central necrosis frequently produces cavitation. Microscopically, malignant squamous cells show keratinization and intercellular bridges.

Tumor differentiation varies from well differentiated to poorly differentiated forms. Local invasion commonly involves adjacent bronchi and mediastinal structures.

Hypercalcemia may occur due to ectopic production of parathyroid hormone-related peptide (PTHrP). Surgical resection offers the best outcome in localized disease.

10. What are the main pathologic features of adenocarcinoma of the lung?

Adenocarcinoma is the most common primary lung cancer and usually arises in the peripheral lung parenchyma. It originates from glandular epithelial cells or type II pneumocytes. Grossly, it appears as a firm gray-white peripheral mass, often associated with pleural retraction.

Microscopically, the tumor forms glands or produces intracellular or extracellular mucin. Several histological patterns, including acinar, papillary, micropapillary, solid, and lepidic, may be present.

Molecular abnormalities involving EGFR, ALK, ROS1, and KRAS are common. The tumor invades pleura, lymphatics, and blood vessels in advanced stages. Regional lymph node and distant metastases may occur early.

Histological subtype and molecular profile guide targeted therapy and prognosis.

11. What are the main morphologic characteristics of bronchioloalveolar carcinoma?

Bronchioloalveolar carcinoma is now classified as adenocarcinoma in situ or lepidic-predominant adenocarcinoma. The tumor usually arises in the peripheral lung and may appear as a solitary nodule or diffuse pneumonic-type consolidation.

Microscopically, neoplastic cells grow along intact alveolar septa in a lepidic pattern without destroying the underlying lung architecture in early lesions. Mucin-producing and non-mucinous variants are recognized.

Stromal, vascular, and pleural invasion are absent in adenocarcinoma in situ but appear in invasive forms. Multiple bilateral lesions may occur. The surrounding alveolar framework is initially preserved.

Prognosis is excellent for non-invasive lesions after complete surgical excision. Invasive lesions behave like conventional adenocarcinoma.

12. Discuss the clinical symptoms caused by bronchioloalveolar carcinoma.

Patients commonly present with persistent cough and gradually progressive dyspnea. Copious watery sputum (bronchorrhea) is a characteristic feature in mucinous tumors. Hemoptysis may occur but is usually mild.

Chest pain is uncommon unless pleural invasion develops. Fever may lead to confusion with pneumonia. Weight loss and fatigue occur in advanced disease. Chest radiographs may show a solitary peripheral nodule or diffuse infiltrative shadows resembling pneumonia.

The tumor often responds poorly to antibiotics because it mimics infection. Early diagnosis depends on imaging, bronchoscopy, biopsy, and histopathological examination.

Prognosis is favorable in localized adenocarcinoma in situ but less favorable in diffuse invasive disease.

13. What are the main pathologic features of small cell carcinoma of the lung?

Small cell carcinoma is a highly malignant neuroendocrine tumor strongly associated with cigarette smoking. It usually arises centrally near the main bronchi. Grossly, it forms a soft gray-white infiltrative mass with extensive necrosis.

Microscopically, the tumor consists of small round or spindle-shaped cells with scant cytoplasm, finely granular chromatin, and numerous mitotic figures. Nuclear molding is a characteristic feature.

The tumor shows extensive vascular invasion and early metastasis. Neuroendocrine markers such as chromogranin, synaptophysin, and CD56 are typically positive. Ectopic hormone production commonly causes paraneoplastic syndromes.

sBecause dissemination occurs early, surgery is rarely useful, and chemotherapy with radiotherapy is the primary treatment.

14. Discuss the origin of large cell carcinoma of the lung.

Large cell carcinoma is an undifferentiated malignant epithelial tumor that lacks the histological features of squamous cell carcinoma, adenocarcinoma, or small cell carcinoma. It probably arises from primitive bronchial epithelial stem cells capable of multidirectional differentiation.

The tumor may occur in either central or peripheral parts of the lung. Grossly, it forms a large soft mass with areas of hemorrhage and necrosis. Microscopically, it contains large pleomorphic cells with abundant cytoplasm, prominent nucleoli, and frequent mitoses. Gland formation and keratinization are absent.

SThe tumor grows rapidly and metastasizes early. Prognosis is generally poor because most patients present with advanced disease. Treatment follows the principles used for non-small cell lung carcinoma.

15. How do lung carcinomas present clinically?

Lung carcinoma often remains asymptomatic during its early stages. Persistent cough is the most common presenting symptom. Hemoptysis, chest pain, dyspnea, and recurrent pneumonia occur because of airway obstruction or local invasion.

Constitutional symptoms include weight loss, anorexia, fatigue, and fever. Hoarseness results from recurrent laryngeal nerve involvement. Superior vena cava obstruction causes facial swelling and venous congestion. Pancoast tumors produce shoulder pain and Horner syndrome due to brachial plexus involvement.

Many patients present with symptoms caused by distant metastases involving the brain, bones, liver, or adrenal glands. Early detection through imaging significantly improves survival.

16. Describe the importance of histologic type and clinical stage in the prognosis and therapy of patients with lung cancer.

Histological classification determines the biological behavior and treatment strategy of lung cancer. Small cell carcinoma is highly aggressive and is treated mainly with chemotherapy and radiotherapy because surgery is rarely beneficial.

Non-small cell carcinomas are managed primarily by surgical resection when localized. Clinical staging using the TNM system is the most important prognostic factor. Early-stage tumors have significantly better survival than advanced metastatic disease.

Molecular testing identifies patients suitable for targeted therapies such as EGFR or ALK inhibitors. Immunotherapy has improved outcomes in selected advanced tumors.

Histological type predicts response to specific treatments. Accurate staging and pathological diagnosis are essential for individualized management and prognosis.

---

17. What are the most frequent paraneoplastic syndromes in patients with lung cancer?

Paraneoplastic syndromes result from ectopic hormone production or immune-mediated mechanisms rather than direct tumor invasion. Small cell carcinoma commonly produces ACTH, causing Cushing syndrome, and ADH, causing syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Squamous cell carcinoma frequently secretes parathyroid hormone-related peptide (PTHrP), resulting in hypercalcemia. Neurological syndromes include Lambert-Eaton myasthenic syndrome and peripheral neuropathy.

Hypertrophic pulmonary osteoarthropathy and digital clubbing are well-recognized manifestations. Hypercoagulability may lead to migratory thrombophlebitis. Dermatomyositis and polymyositis occur occasionally.

Recognition of paraneoplastic syndromes may facilitate early diagnosis of occult lung cancer. Successful treatment of the primary tumor often improves these manifestations.

18. List the main histologic subtypes of neuroendocrine tumors of the lungs.

Pulmonary neuroendocrine tumors are classified into four major histological subtypes based on differentiation and biological behavior. Typical carcinoid tumor is a low-grade neuroendocrine neoplasm with an excellent prognosis. 

Atypical carcinoid tumor is an intermediate-grade tumor with increased mitotic activity and focal necrosis. Large cell neuroendocrine carcinoma is a high-grade malignant tumor with aggressive clinical behavior. Small cell carcinoma is the most aggressive neuroendocrine carcinoma and metastasizes early.

All neuroendocrine tumors express markers such as chromogranin, synaptophysin, and CD56. Prognosis worsens progressively from typical carcinoid to small cell carcinoma. Histological grading guides treatment and predicts survival.

19. What are the main clinical and pathologic characteristics of bronchial carcinoids?

Bronchial carcinoids are well-differentiated neuroendocrine tumors arising from Kulchitsky cells of the bronchial mucosa. They account for a small proportion of primary lung tumors and usually occur in younger patients.

Most tumors arise centrally within the major bronchi and produce cough, wheezing, recurrent pneumonia, or hemoptysis because of bronchial obstruction. Grossly, they appear as well-circumscribed, highly vascular, polypoid masses projecting into the bronchial lumen. Microscopically, uniform neuroendocrine cells are arranged in nests, trabeculae, or rosettes.

Typical carcinoids have few mitoses and no necrosis, whereas atypical carcinoids show increased mitotic activity and focal necrosis. Carcinoid syndrome is uncommon because vasoactive substances are usually metabolized in the lungs. Surgical excision is the treatment of choice.

The prognosis is excellent for typical carcinoids and intermediate for atypical carcinoids.

20. List the usual features of metastatic tumors in the lungs.

 

The lungs are one of the most common sites of metastatic spread because they receive the entire cardiac output through the pulmonary circulation. Metastases commonly arise from cancers of the breast, colon, kidney, thyroid, prostate, liver, and malignant melanoma.

Grossly, metastatic tumors usually appear as multiple, well-circumscribed, rounded nodules of varying sizes scattered throughout both lungs. Some tumors produce diffuse lymphangitic spread or pleural involvement.

Histologically, the metastatic tumor resembles the primary malignancy. Patients may be asymptomatic or present with cough, dyspnea, chest pain, or hemoptysis. Chest CT is highly sensitive for detecting pulmonary metastases.

Treatment depends on the primary tumor, extent of metastasis, and patient's clinical condition. Pulmonary metastases generally indicate advanced-stage malignancy and carry a guarded prognosis.

---

 DR.C.GANESAN M.D

PROFESSOR OF MEDICINE